Sitting Down With… Tim Clover, CEO of Rayner
What route did you take to become CEO of Rayner?
I began my career in R&D but, at that time, I wasn’t sure if it was for me. Now, in the middle of my career, R&D is one of my passions within the company. Nevertheless, I switched from a PhD to an MBA and went up through the commercial company ranks. I was involved in Zeiss’ acquisition of Humphrey Instruments from Allergan and, by virtue of that, I found my way into Allergan. There, I was lucky enough to work with Jim Mazzo and some other interesting industry figures. I then became one of the early members of AMO (Advanced Medical Optics), when it spun off from Allergan – in fact, I worked on that transition.
At that point, my career took a slightly more entrepreneurial turn. I span a company out of Oxford University, and it ended up being quite successful, so I found myself in Fidelity, running a private equity fund. As part of that role I purchased a group of eye hospitals and turned them into Optegra – a leading worldwide provider of eye surgery centers operating from 23 specialist eye hospitals across Europe. In 2014 I became a non-executive director of Rayner with a brief to develop a strategic growth plan for the company which led to me being appointed CEO in 2015.
Read the full article now
Log in or register to read this article in full and gain access to The Ophthalmologist’s entire content archive. It’s FREE and always will be!
Or register now - it’s free and always will be!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Ophthalmologist magazine
Or Login via Social Media
By clicking on any of the above social media links, you are agreeing to our Privacy Notice.